NLRP3 and metabolic dysfunction-associated steatotic liver disease: In PLWH with MASLD or type 2 diabetes, lipotoxicity, oxidative stress, and activation of the NLRP3 inflammasome amplify the production of inflammatory cytokines (IL-6, TNF-α), with deleterious effects on mitochondrial function and immune homeostasis [199].